Bank of New York Mellon Corp Lowers Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

Bank of New York Mellon Corp lowered its holdings in Exponent, Inc. (NASDAQ:EXPOFree Report) by 3.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 416,091 shares of the business services provider’s stock after selling 13,196 shares during the period. Bank of New York Mellon Corp owned 0.82% of Exponent worth $33,728,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its stake in shares of Exponent by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock worth $476,284,000 after purchasing an additional 67,296 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Exponent by 0.9% during the fourth quarter. Geode Capital Management LLC now owns 1,519,584 shares of the business services provider’s stock valued at $135,419,000 after purchasing an additional 13,932 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Exponent by 1.1% during the fourth quarter. Invesco Ltd. now owns 1,188,373 shares of the business services provider’s stock valued at $105,884,000 after purchasing an additional 13,263 shares during the last quarter. Northern Trust Corp grew its holdings in Exponent by 7.4% in the 4th quarter. Northern Trust Corp now owns 770,270 shares of the business services provider’s stock worth $68,631,000 after buying an additional 53,227 shares in the last quarter. Finally, Wells Fargo & Company MN grew its holdings in Exponent by 0.6% in the 4th quarter. Wells Fargo & Company MN now owns 739,710 shares of the business services provider’s stock worth $65,908,000 after buying an additional 4,704 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Performance

Shares of NASDAQ:EXPO opened at $72.34 on Wednesday. Exponent, Inc. has a one year low of $72.30 and a one year high of $115.75. The stock has a fifty day moving average of $76.44 and a 200-day moving average of $81.84. The company has a market capitalization of $3.67 billion, a PE ratio of 35.29 and a beta of 0.90.

Exponent (NASDAQ:EXPOGet Free Report) last posted its earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping the consensus estimate of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to the consensus estimate of $134.63 million. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The business’s quarterly revenue was up .2% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. As a group, research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.66%. The ex-dividend date of this dividend was Friday, June 6th. Exponent’s payout ratio is presently 58.54%.

Insider Activity at Exponent

In other Exponent news, VP Bradley A. James sold 2,694 shares of the firm’s stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $79.52, for a total transaction of $214,226.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, VP John Pye sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the transaction, the vice president owned 29,204 shares of the company’s stock, valued at approximately $2,228,849.28. This represents a 6.41% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,267 shares of company stock worth $489,120. Company insiders own 1.60% of the company’s stock.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.